Top Glove Corporation Bhd (TGLVY)
OTHER OTC:TGLVY
Top Page
Top Glove Bhd
(OTC:TGLVY)
Select Model
Select Model
Rating:61Neutral
Price Target:
$0.73
▲(21.33% Upside)
Action:ReiteratedDate:03/29/26
The score is driven primarily by improving financial performance (return to profitability and positive free cash flow) supported by a strong, low-leverage balance sheet. Offsetting this are weak technical momentum signals (negative MACD and oversold readings) and a high P/E that makes the stock less attractive on valuation despite the high dividend yield.
Positive Factors
Balance Sheet Strength
Low leverage (debt well under 25% of equity) materially reduces refinancing and solvency risk, giving Top Glove capacity to fund working capital, invest in plant, or return cash during industry cycles. This structural financial flexibility supports durability across downturns.
Negative Factors
Modest, Volatile Profitability
Low single-digit margins limit earnings power and make returns on equity modest. Combined with a volatile multi-year performance track record, this implies earnings are sensitive to demand swings and operational shocks, constraining sustainable shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Low leverage (debt well under 25% of equity) materially reduces refinancing and solvency risk, giving Top Glove capacity to fund working capital, invest in plant, or return cash during industry cycles. This structural financial flexibility supports durability across downturns.
Read all positive factors
Top Glove Bhd (TGLVY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.63B
Dividend Yield0.65%
Average Volume (3M)2.26K
Price to Earnings (P/E)34.6
Beta (1Y)-0.27
Revenue Growth26.85%
EPS Growth8150.00%
CountryUS
Employees11,000
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,054,432,900
10 Day Avg. Volume5,160
30 Day Avg. Volume2,259
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)1.17
Price to Sales (P/S)1.59
P/FCF Ratio35.45
Enterprise Value/Market Cap4.34
Enterprise Value/Revenue1.97
Enterprise Value/Gross Profit3.93
Enterprise Value/Ebitda14.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Top Glove Bhd Business Overview & Revenue Model
Company Description
Top Glove Bhd (TGLVY) is a leading global manufacturer of disposable rubber gloves, headquartered in Malaysia. Established in 1991, the company operates primarily in the healthcare and industrial sectors, producing a wide range of gloves including...
How the Company Makes Money
Top Glove makes money primarily by manufacturing and selling disposable gloves to customers worldwide. Revenue is generated from (1) product sales across different glove categories (e.g., nitrile and natural rubber/latex gloves) and use-cases (med...
Top Glove Bhd Financial Statement Overview
Summary
Income Statement
60
Neutral
Balance Sheet
78
Positive
Cash Flow
64
Positive
| Breakdown | TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.58B | 3.49B | 2.51B | 2.26B | 5.57B | 16.36B |
| Gross Profit | 1.80B | 89.01M | 265.32M | 64.32M | 953.38M | 11.10B |
| EBITDA | 493.50M | 455.66M | 266.09M | -544.66M | 711.00M | 10.35B |
| Net Income | 141.67M | 132.18M | -18.27M | -878.61M | 275.73M | 7.76B |
Balance Sheet | ||||||
| Total Assets | 6.32B | 6.27B | 6.96B | 7.06B | 8.12B | 9.78B |
| Cash, Cash Equivalents and Short-Term Investments | 684.06M | 560.67M | 933.23M | 942.82M | 946.75M | 2.51B |
| Total Debt | 857.67M | 849.86M | 422.09M | 581.85M | 417.07M | 482.38M |
| Total Liabilities | 1.55B | 1.49B | 1.12B | 1.14B | 1.32B | 2.56B |
| Stockholders Equity | 4.74B | 4.76B | 5.81B | 5.89B | 6.75B | 7.17B |
Cash Flow | ||||||
| Free Cash Flow | 247.40M | 156.31M | -122.54M | -244.10M | -774.72M | 6.49B |
| Operating Cash Flow | 351.73M | 300.16M | 20.70M | 121.04M | 178.81M | 7.83B |
| Investing Cash Flow | 82.52M | 450.90M | 247.46M | -383.26M | 132.42M | -1.25B |
| Financing Cash Flow | -414.87M | -803.47M | -181.66M | 94.75M | -740.35M | -6.90B |
Top Glove Bhd Technical Analysis
Positive
0.60
Price Trends
0.57
Positive
0.56
Positive
0.57
Positive
Market Momentum
0.04
Negative
74.26
Negative
97.69
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TGLVY, the sentiment is Positive. The current price of 0.6 is below the 20-day moving average (MA) of 0.61, above the 50-day MA of 0.57, and above the 200-day MA of 0.57, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 74.26 is Negative, neither overbought nor oversold. The STOCH value of 97.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TGLVY.
Top Glove Bhd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $43.91B | 28.46 | 6.93% | 2.13% | 8.23% | -2.04% | |
65 Neutral | $8.47B | 20.41 | 14.67% | 1.50% | 2.50% | 25.05% | |
64 Neutral | $13.89B | 30.60 | 4.83% | ― | 5.06% | -4.47% | |
61 Neutral | $1.63B | 34.63 | 3.01% | 0.65% | 26.85% | 8150.00% | |
57 Neutral | $3.10B | 4,802.44 | 0.04% | ― | -0.81% | 93.27% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $8.85B | -10.24 | -13.78% | 2.75% | -21.20% | -325.40% |
* Healthcare Sector Average
TGLVY
Top Glove Bhd
0.79
0.07
9.42%
ATR
AptarGroup
131.50
-10.70
-7.52%
BAX
Baxter International
17.15
-10.31
-37.55%
BDX
Becton Dickinson
154.22
-0.71
-0.46%
COO
Cooper Co
71.21
-6.25
-8.07%
ICUI
ICU Medical
125.68
-16.97
-11.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.